Skip to the page

Data / Form D filings / New Frontier Bio, Inc.

New Frontier Bio, Inc.: Form D filings

New Frontier Bio, Inc., a company in Beverly, MA, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on June 21, 2024, reports $308,723 sold of a $2 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
48 DUNHAM RIDGE, SUITE 5600, Beverly, MA, 01915
Phone
(617) 834-5809
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1840005

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 21, 2024New notice$2,000,000$308,723$1,691,2776May 13, 2024sec.gov
Sep 26, 2022New notice$12,000,000$8,900,000$3,100,00011Sep 13, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Kevin KongExecutive Officer
Serge SchoenDirector
Vincent MaiDirector
Kaiyuan WangDirector
Stephen SmithExecutive Officer, Director, Promoter
James LintonDirector

Other companies in Massachusetts that filed recently

Every Form D from the week of Jun 17, 2024 · All recent filings in Massachusetts · All recent Other filings

Read from SEC EDGAR. Amount sold is what New Frontier Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.